H15.052

Clinical Causes: Autoimmune disorders such as rheumatoid arthritis or granulomatosis with polyangiitis Degenerative scleral conditions related to aging Previous eye trauma or surgeries leading to scleral weakness Infections causing inflammation and tissue breakdown Genetic predispositions affecting connective tissue integrity

Key Symptoms: Gradual thinning of the sclera visible as a blue or transparent area at the eye's surface Localized pain or discomfort in the affected eye Sensitivity to light (photophobia) Possible redness or inflammation around the scleral thinning Decreased vision if the condition progresses or affects deeper structures Appearance of a small, localized bulge or perforation in advanced cases

Diagnosis Path: Diagnosis involves a comprehensive eye examination performed by an ophthalmologist, including slit-lamp biomicroscopy to assess scleral thinning and perforation. Additional tests may include imaging studies such as ultrasound biomicroscopy or anterior segment optical coherence tomography (OCT) to evaluate the extent of tissue loss and rule out other conditions. Blood tests may be recommended to identify associated autoimmune disorders.

Treatment Protocols: Management of scleromalacia perforans often aims to halt progression and preserve eye structure and function. Treatment options include: - Addressing underlying autoimmune or inflammatory causes with immunosuppressive medications - Surgical interventions to reinforce the sclera or repair perforations if present - Regular monitoring to detect early signs of deterioration - Use of protective measures to avoid injury or further trauma - Coordination with rheumatologists or other specialists to manage systemic conditions Early detection and tailored treatment strategies are critical in preventing serious complications such as scleral rupture or vision loss.